[Progress of researches on liver-specific transcriptional regulatory sequence].

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi

Center of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.

Published: April 2009

AI Article Synopsis

  • Gene therapy has rapidly advanced, but concerns remain about the safety and effectiveness of gene expression in specific times and locations.
  • Using tissue or cell-specific transcriptional regulatory elements can enhance the precision of gene expression, particularly in targeting hepatic tissue for liver-related conditions.
  • Recent research highlights advancements in liver-specific transcriptional regulatory sequences, which are valuable for understanding disease mechanisms and improving gene therapy outcomes for liver diseases.

Article Abstract

Gene therapy is a fast developing therapeutics in recent years. Now, the point at issue that restricts the development of gene therapy is the safety and effectivity of gene expression in space, time series and location. Tissular or cellular specific transcriptional regulatory element can make precise and effective expression of exogenous gene in specified tissue and cell, thus increasing the safety and effectivity of gene expression. This has been a hot spot in gene therapy. Now, researches indicate that hepatic tissue has liver-specific transcriptional regulatory sequence. The regulatory sequences can promote gene expression only in hepatic tissue; they are widely used in transgenic animal and gene therapy. They can serve as a basis for the researches in the pathogenic mechanism and gene therapy of liver-related diseases. New achievements in the studies on liver-specific transcriptional regulatory sequence are reviewed in this article.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gene therapy
20
transcriptional regulatory
16
liver-specific transcriptional
12
gene expression
12
gene
9
safety effectivity
8
effectivity gene
8
hepatic tissue
8
regulatory sequence
8
regulatory
5

Similar Publications

Targeting RNA splicing modulation: new perspectives for anticancer strategy?

J Exp Clin Cancer Res

January 2025

Department of Pharmacology, School of Pharmacy, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning Province, 110122, P. R. China.

The excision of introns from pre-mRNA is a crucial process in the expression of the majority of genes. Alternative splicing allows a single gene to generate diverse mRNA and protein products. Aberrant RNA splicing is recognized as a molecular characteristic present in almost all types of tumors.

View Article and Find Full Text PDF

Background: Vibrio parahaemolyticus is a marine bacterium causing seafood-associated gastrointestinal illness in humans and acute hepatopancreatic necrosis disease (AHPND) in shrimp. Bacteriophages have emerged as promising biocontrol agents against V. parahaemolyticus.

View Article and Find Full Text PDF

High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota.

Gut Pathog

January 2025

Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, China.

Background: Helicobacter pylori (H. pylori) eradication regimens may have different effects on the gut microbiota. Few studies have analyzed the safety of high-dose dual therapy (HDDT) from a micro-ecological perspective.

View Article and Find Full Text PDF

Background: Circular (circ)RNAs have emerged as crucial contributors to cancer progression. Nonetheless, the expression regulation, biological functions, and underlying mechanisms of circRNAs in mediating hepatocellular carcinoma (HCC) progression remain insufficiently elucidated.

Methods: We identified circUCK2(2,3) through circRNA sequencing, RT-PCR, and Sanger sequencing.

View Article and Find Full Text PDF

Multiple myeloma (MM) remains an incurable hematological malignancy that necessitates the identification of novel therapeutic strategies. Here, we report that intracellular levels of very long chain fatty acids (VLCFAs) control the cytotoxicity of MM chemotherapeutic agents. Inhibition of VLCFA biosynthesis reduced cell death in MM cells caused by the proteasome inhibitor, bortezomib.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!